Why Should Independent Pharmacies Stock Pet Medications?
Drug Topics
AUGUST 29, 2023
Caring for pets is easier when a pharmacist is involved.
Tue.Aug 29, 2023
469 
‘We need to do better:’ A biotech CEO on standing apart from the crowd
PharmaVoice
AUGUST 29, 2023
The CEO of Cullinan Oncology is taking a small biotech to the next step and believes the temporary financial barriers are smaller than scientific progress.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Filling Prescriptions for Pet Patients: Best Practices
Drug Topics
AUGUST 29, 2023
Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.
5 of the best places to work in pharma, according to employees
PharmaVoice
AUGUST 29, 2023
Work-life balance is one major common denominator among the top-ranked pharma employers on Glassdoor.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
SSRIs May Mitigate Negative Health Outcomes Associated With Postnatal Depression
Drug Topics
AUGUST 29, 2023
Serotonin reuptake inhibitors (SSRIs) are the preferred medication to treat postnatal depression, but there is a lack of evidence about their long-term impact on women and their children.
FDA Approves Luspatercept-aamt for First-Line Treatment of Anemia in Adults With Lower-Risk Myelodysplastic Syndromes
Pharmacy Times
AUGUST 29, 2023
Luspatercept-aamt (Reblozyl) approved to treat adults with very low- to intermediate-risk myelodysplastic syndrome who may require regular red blood cell transfusions.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Study: New Vaccine Modality Using Biopolymer Particles Shows Promise in Group A Streptococcus
Pharmacy Times
AUGUST 29, 2023
Investigators from Griffith University stated that technology has helped the development of vaccines that are safe to use and induce strong immune responses against Strep A.
An overview of AI in pharma – Part 2
pharmaphorum
AUGUST 29, 2023
An overview of AI in pharma – Part 2 Mike.
CDC Recommends Beyfortus for Routine Use to Protect Infants, Young Children Against Respiratory Syncytial Virus
Pharmacy Times
AUGUST 29, 2023
Nirsevimab (Beyfortus) is the first respiratory syncytial virus (RSV) preventative drug to be approved by the FDA, and can protect infants through their first RSV season for up to 5 months.
BMS grabs key approval for Reblozyl in MDS
pharmaphorum
AUGUST 29, 2023
BMS grabs key approval for Reblozyl in MDS Phil.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Supplemental Biologics License Application Submitted to Expand Approval of Rybrevant for NSCLC
Pharmacy Times
AUGUST 29, 2023
The supplemental biologics license application for amivantamab-vmjw (Rybrevant) is supported by data from the phase 3 PAPILLON trial, evaluating the efficacy and safety of the drug in combination with chemotherapy for those with non–small cell lung cancer.
BlueRock clears key hurdle in Parkinson's stem cell trial
pharmaphorum
AUGUST 29, 2023
BlueRock clears key hurdle in Parkinson's stem cell trial Phil.
From Shortages to Solutions: Enhancing Drug Manufacturing Through Innovation
Pharmacy Times
AUGUST 29, 2023
Technology and regulations can revolutionize drug manufacturing and ensure a stable supply of medications.
Opinion: How the twin crises of climate change and poor public housing are harming people’s health
STAT
AUGUST 29, 2023
Climate change is an existential problem for human health. As climate change intensifies, the frequency and severity of extreme weather events such as heatwaves, cold fronts, and floods will increase. Undoubtedly, this will result in devastating effects for human health and wellbeing, contributing to increased susceptibility to infectious diseases, an already growing mental health crisis, and, most directly, heat-related mortality.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Patients With Cancer Engaging in Administrative Payment Tasks May Choose to Delay or Not Adhere to Treatment
Pharmacy Times
AUGUST 29, 2023
Patients with cancer and survivors of cancer that had engaged in administrative tasks to effectively estimate costs or pay for care was associated with an 18% increase in cost-related treatment delays or treatment nonadherence.
STAT+: As competition looms, Insulet sues a rival for allegedly stealing trade secrets on diabetes tech
STAT
AUGUST 29, 2023
Insulet filed a lawsuit this month against its rival EOFlow, accusing it of stealing trade secrets in a case that could shake up the diabetes technology market and throw a wrench in Medtronic’s planned $738 million acquisition of EOFlow. Insulet alleges that the South Korea-based EOFlow copied the design for its only product, a patch pump, called the Omnipod that delivers insulin to people with diabetes.
Artificial Intelligence for Comprehensive Diagnostics, Examinations in Acute Coronary Syndromes
Pharmacy Times
AUGUST 29, 2023
Pharmacists can actively engage in the implementation of the Comprehensive Diagnostics and Examinations in Acute Coronary Syndromes pathway within the hospital or health care system.
Mallinckrodt files for second bankruptcy
Drug Store News
AUGUST 29, 2023
Mallinckrodt said it intends to pay vendors and suppliers in the ordinary course, including for any pre-petition amounts owed at the time of filing.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FTC hold raises hope of Amgen/Horizon deal progress
pharmaphorum
AUGUST 29, 2023
FTC hold raises hope of Amgen/Horizon deal progress Phil.
Learn the short- and long-term effects of Adderall on the body
The Checkup by Singlecare
AUGUST 29, 2023
If you have attention-deficit/hyperactivity disorder (ADHD), your healthcare provider may recommend or prescribe the stimulant medication Adderall to help minimize your symptoms. Adderall can be an essential tool for improving the daily executive functioning of people with ADHD. It helps with thinking more clearly, focusing energy on singular projects, and coping better with everyday challenges like impulsivity and hyperactivity.
GB first to approve Roche's subcutaneous Tecentriq
pharmaphorum
AUGUST 29, 2023
GB first to approve Roche's subcutaneous Tecentriq Phil.
Clinical trials: How AI can help providers stay TMF inspection-ready
Pharmaceutical Technology
AUGUST 29, 2023
The clinical trials industry is facing a number of hurdles, but AI and digitalisation are being heralded as key to overcoming them, particularly when it comes to preparing for inspections and audits
Pfizer's tornado-hit plant will soon restart production
pharmaphorum
AUGUST 29, 2023
Pfizer's tornado-hit plant will soon restart production Phil.
Opinion: Every senator should fill out a legislative advance directive
STAT
AUGUST 29, 2023
Advance directives were born in the Senate. Now they can help preserve the dignity of its aging members. In Cruzan v. Director, Missouri Department of Health , the parents of Nancy Cruzan, a young woman who had been left in a permanent vegetative state after a car accident, wanted the right to remove her life support. In 1990, the Supreme Court ruled in favor of her parents, affirming the constitutional right to refuse life-sustaining treatment.
Walmart reportedly cutting pharmacists' pay, hours
Drug Store News
AUGUST 29, 2023
The cuts are aimed at pharmacists in higher wage brackets and underscore the new pressures at Walmart pharmacies, per a Reuters report.
First 10 drugs subject to Medicare negotiations named
pharmaphorum
AUGUST 29, 2023
First 10 drugs subject to Medicare negotiations named Phil.
Overcoming the challenges of HIPAA-compliant marketing, analytics & advertising
Fierce Healthcare
AUGUST 29, 2023
Healthcare providers continue to misuse patient data | HIPAA compliance is challenging, but healthcare organizations must cultivate it in all their operations, including marketing activities.
European regulatory perspective on nitrosamine mitigation strategies
European Pharmaceutical Review
AUGUST 29, 2023
Experts at the European Medicines Agency (EMA) have provided a regulatory perspective on risk factors and mitigation strategies for nitrosamine impurities in human drug products. The paper highlighted an Article 31 referral into medicine safety which began in the EU in September 2019. Above acceptable levels of N-nitrosodimethylamine (NDMA) had been detected in ranitidine tablets and thus investigated.
Anthem launching AI-enabled virtual-first plans in 2 more states
Fierce Healthcare
AUGUST 29, 2023
Earlier this year, Anthem Blue Cross and Blue Shield unveiled a new virtual-first plan that harnesses artificial intelligence to streamline health services for members, the insurer
Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing
BioPharm
AUGUST 29, 2023
Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.
AHA: Biden admin's short-term plan crackdown a good start on addressing 'convoluted' coverage gaps
Fierce Healthcare
AUGUST 29, 2023
Hospitals are on board with the Biden administration’s increased scrutiny of “inadequate” short-term health plans, and are hoping that the federal government will go further in its crackdown on pay | In a letter to CMS, the American Hospital Association commended the restrictions on so-called "junk plans" and floated mid-year coverage changes and high-deductible health plans as openings for future rulemaking.
Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation
Fierce Pharma
AUGUST 29, 2023
As Moderna’s COVID vaccine patent lawsuits wind their way through courts around the globe, Pfizer and BioNTech contend their rival is trying to monopolize the entire mRNA field. | Pfizer and BioNTech have filed a pair of petitions seeking to invalidate two Moderna patents at the heart of the legal proceedings between the mRNA juggernauts.
Pass the ABIM Sleep Medicine Certification Exam
Board Vitals - Pharmacist
AUGUST 29, 2023
As a medical professional specializing in sleep medicine, achieving the American Board of Internal Medicine (ABIM) Sleep Medicine Certification is a testament to your expertise and dedication in this specialized field. This blog post aims to shed light on the ABIM Sleep Medicine Certification Exam , providing valuable insights and tips to help you prepare effectively and confidently ace this significant milestone in your career.
Let's personalize your content